Literature DB >> 20451691

Comparison across races of peak oxygen consumption and heart failure survival score for selection for cardiac transplantation.

Ayumi Goda1, Lars H Lund, Donna M Mancini.   

Abstract

The aim of the present study was to determine whether peak oxygen consumption (VO(2)) and the Heart Failure Survival Score (HFSS) predict prognosis in European-American, African-American, and Hispanic-American patients with chronic heart failure referred for heart transplantation. The peak VO(2) and the HFSS have previously been shown to effectively risk stratify patients with chronic heart failure and are criteria for the listing for heart transplantation. However, the effect of race on the predictive value of these variables has not been studied. A total of 715 patients with congestive heart failure (433 European American, 126 African American, 123 Hispanic American, and 33 other), who had been referred for heart transplantation, underwent cardiopulmonary exercise testing with measurement of the peak VO(2) and calculation of the HFSS. A total of 354 patients had died or undergone urgent heart transplantation or implantation of a left ventricular assist device during the 962 +/- 912 days of follow-up. On univariate and multivariate Cox hazard analysis, both peak VO(2) and the HFSS were powerful prognostic markers in the overall cohort and in the separate races. In the receiver operating characteristic curve analysis, the areas under the curve at 1 and 2 years of follow-up were greater for the HFSS than for peak VO(2). In conclusion, HFSS and peak VO(2) can be used for transplant selection; however, in the era of modern therapy and across races and genders, the HFSS might perform better than the peak VO(2). Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20451691     DOI: 10.1016/j.amjcard.2009.12.067

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  An Appraisal of Biomarker-Based Risk-Scoring Models in Chronic Heart Failure: Which One Is Best?

Authors:  Barbara S Doumouras; Douglas S Lee; Wayne C Levy; Ana C Alba
Journal:  Curr Heart Fail Rep       Date:  2018-02

Review 2.  Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance.

Authors:  David C Poole; Daniel M Hirai; Steven W Copp; Timothy I Musch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-18       Impact factor: 4.733

Review 3.  Current indications for transplantation: stratification of severe heart failure and shared decision-making.

Authors:  Darko Vucicevic; Lily Honoris; Federica Raia; Mario Deng
Journal:  Ann Cardiothorac Surg       Date:  2018-01

4.  Gender aspects in clinical presentation and prognostication of chronic heart failure according to NT-proBNP and the Heart Failure Survival Score.

Authors:  Jennifer Franke; Andreas Lindmark; Matthias Hochadel; Christian Zugck; Eva Koerner; Jeannette Keppler; Philipp Ehlermann; Ralph Winkler; Ralf Zahn; Hugo A Katus; Jochen Senges; Lutz Frankenstein
Journal:  Clin Res Cardiol       Date:  2014-11-06       Impact factor: 5.460

Review 5.  Comparison among different multiparametric scores for risk stratification in heart failure patients with reduced ejection fraction.

Authors:  Ugo Corrà; Alessandra Magini; Stefania Paolillo; Maria Frigerio
Journal:  Eur J Prev Cardiol       Date:  2020-12       Impact factor: 7.804

Review 6.  Are the current evaluation tools for advanced therapies biased?

Authors:  Raymond C Givens
Journal:  Curr Opin Cardiol       Date:  2021-05-01       Impact factor: 2.108

7.  Ceruloplasmin, NT-proBNP, and Clinical Data as Risk Factors of Death or Heart Transplantation in a 1-Year Follow-Up of Heart Failure Patients.

Authors:  Ewa Romuk; Wojciech Jacheć; Ewa Zbrojkiewicz; Alina Mroczek; Jacek Niedziela; Mariusz Gąsior; Piotr Rozentryt; Celina Wojciechowska
Journal:  J Clin Med       Date:  2020-01-03       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.